Clinical Trial Update: A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind, placebo-controlled crossover trial evaluating safety and efficacy of AGY in celiac disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• AGY

Snippet

Sponsor: Igy Inc. | Conditions: Celiac Disease | Phase 2 | Status: COMPLETED